<SEC-DOCUMENT>0001104659-26-029912.txt : 20260318
<SEC-HEADER>0001104659-26-029912.hdr.sgml : 20260318
<ACCEPTANCE-DATETIME>20260318080520
ACCESSION NUMBER:		0001104659-26-029912
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260318
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260318
DATE AS OF CHANGE:		20260318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MetaVia Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		26765502

	BUSINESS ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeuroBo Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20191231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mtva-20260318x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 11.2.0.5 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 3/17/2026 7:11:52 PM -->
<!-- iXBRL Library version: 1.0.9448.42501 -->
<!-- iXBRL Service Job ID: 00000000-0000-0000-0000-000000000000 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:mtva="http://metaviatx.com/20260318" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title>METAVIA INC._March 18, 2026</title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityCentralIndexKey" id="Tc_URXl72dnfkWR-I_AemKwCA_1_1">0001638287</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:AmendmentFlag" id="Tc_uOaa9lgrOkSeFNrK6tDWhQ_2_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mtva-20260318.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-03-18</xbrli:startDate><xbrli:endDate>2026-03-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:41.04pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1px solid #000000;border-top:2.25pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_a8cfc5aa_7156_42e9_b20f_3ae014dc0fb5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">WASHINGTON, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:DocumentType" id="Narr_7hDbU-YJI0ezpq8jnyPwNQ"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_4lQoiCeT-U60TfTPnlFUmw"><b style="font-weight:bold;">March 18, 2026</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="mtva-20260318x8k001.jpg" alt="Graphic" style="display:inline-block;height:41.04pt;width:214.56pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:16pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityRegistrantName" id="Narr_XktjUJNBsUimWCLW5IRopg"><b style="font-weight:bold;">METAVIA INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(Exact name of Registrant as Specified in Its Charter)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_13452a04_9467_4692_bd89_690379252b8f"></a><a id="Tc_AiyLc9u6z0i9ByqOP-so9A_2_0"></a><a id="Tc_gk34Yq7n7UazqJs6GJIQiw_2_2"></a><a id="Tc_ON0et9QFUk-K8mtaf1ta2w_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style=""><td style="vertical-align:bottom;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_M3qaim0Qv0Sg1qZkC7p9Lw_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityFileNumber" id="Tc_xz2eznqK_0uSO0GwGp43QA_1_2"><b style="font-weight:bold;">001-37809</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityTaxIdentificationNumber" id="Tc_w8q37vOyWEqUQm5AsInH1g_1_4"><b style="font-weight:bold;">47-2389984</b></ix:nonNumeric></p></td></tr><tr style=""><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other jurisdiction</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">of incorporation)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_a03c4018_f776_4435_ac00_d380f9b56282"></a><a id="Tc_EMPVPdaE6Eyw5E0JZvV8Tg_1_0"></a><a id="Tc_XmTYCw4Pikibs65cc4zopw_2_0"></a><a id="Tc_XfnTthfluEO3DKaLPDC0rg_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style=""><td style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityAddressAddressLine1" id="Narr_EaNrAZHOh0OMhh9XN016Cg"><b style="font-size:9pt;font-weight:bold;">545 Concord Avenue</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityAddressAddressLine2" id="Narr_i2ozApFXb0eomZ_YyPPKLQ"><b style="font-size:9pt;font-weight:bold;">Suite 210</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityAddressCityOrTown" id="Narr_XFalxxEX60-f4IofNfLOxw"><b style="font-size:9pt;font-weight:bold;">Cambridge</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_TAoDygC1pEqd6zsD864Dyg"><b style="font-size:9pt;font-weight:bold;">Massachusetts</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:EntityAddressPostalZipCode" id="Tc_FCA4F41oPEa6veF6N967iA_1_2"><b style="font-size:9pt;font-weight:bold;">02138</b></ix:nonNumeric></p></td></tr><tr style=""><td style="vertical-align:top;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:top;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:CityAreaCode" id="Narr_P6e_vh-rkEukpienKzgaLQ"><b style="font-weight:bold;">857</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:LocalPhoneNumber" id="Narr_h6p6l6nvokyF2OkuDUVMLQ"><b style="font-weight:bold;">702-9600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><a id="_e51ff3d8_d6f6_44c9_b338_8f565e4a1604"></a><a id="Tc_a2Sg9fITg0Oq6RfMuu5oeg_1_1"></a><a id="Tc_DWxF520uIEegNp2unn4eBA_2_1"></a><a id="Tc_HufXDyVbl028c9wRcfwt0Q_3_1"></a><a id="Tc_qqp4GO9TwU6LkrdOGx5VjQ_4_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style=""><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Tc_EA6AWe_gB0Cd4VIt-7RBKQ_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td></tr><tr style=""><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Tc_G5ZH-Gs2BkiA1FafYlElgA_2_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td></tr><tr style=""><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Tc_WiRExuoP806a_ij_tQeRtw_3_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td></tr><tr style=""><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Tc_2n2ekDY9L0yyih0yUBLeTw_4_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><a id="_0c311cdb_c736_4079_9d07_0deae2867d84"></a><a id="Tc_YarDv2aJvU-eyOahwW6obw_1_0"></a><a id="Tc_17dl9VlGckC9bXU826nHdA_1_2"></a><a id="Tc_aZjIa9kMBEiB3UkcLXKehQ_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:14.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:41.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style=""><td style="vertical-align:bottom;width:39.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Title of each class</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#8203;&#160;&#8203;&#160;&#8203;</p></td><td style="vertical-align:bottom;width:14.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Trading</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Symbol(s)</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#8203;&#160;&#8203;&#160;&#8203;</p></td><td style="vertical-align:bottom;width:41.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Name of each exchange on which registered</p></td></tr><tr style=""><td style="vertical-align:top;width:39.74%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:Security12bTitle" id="Tc_zumNpxG6mEi4rhugSZ-rUw_2_0">Common Stock, par value $0.001 per share</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:14.66%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" name="dei:TradingSymbol" id="Tc_aWQu5QanLEigH6bUjLMBrQ_2_2">MTVA</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:41.46%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_H5oSULDcT0OdwMSPv8ikHg_2_4">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Emerging growth company&#160;<ix:nonNumeric contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_PlZ8jYcOwkmwA35Y42O0OQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:2.25pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_764cec70_67f2_42eb_9696_f748148f0b07"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 7.01.</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span></span><b style="font-weight:bold;background:#ffffff;">Regulation FD Disclosures.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">On March 18, 2026, MetaVia Inc. (the &#8220;Company&#8221;) issued a press release announcing that the Institutional Review Board at Clinical Pharmacology of Miami has approved the Company&#8217;s Phase 1 Part 3 clinical trial of its lead asset, DA-1726, a novel, dual oxyntomodulin analog agonist targeting both GLP-1 and glucagon receptors. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K (this &#8220;Report&#8221;) and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Information contained on or accessible through any website reference in the press release is not part of, or incorporated by reference in, this Report, and the inclusion of such website addresses in this Report by incorporation by reference of the press release is as inactive textual references only.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The information in Item 7.01 of this Report, including Exhibit 99.1 attached hereto, is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the&#160;Securities Exchange Act of 1934, as amended (the&#160;&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the&#160;Securities Act of 1933, as amended, or the&#160;Exchange Act, except as expressly set forth by specific reference in such filing. The Company&#8217;s submission of this Report shall not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of&#160;Regulation FD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt -20.15pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p><a id="_d81309ee_3b1a_4581_aff0_30a2c16d3daf"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt -20.15pt 8pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 8.01. </b></span><b style="font-weight:bold;">Other Events.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:8pt;text-align:justify;background:#ffffff;margin:0pt 3.8pt 0pt 0pt;">On March 18, 2026, the Company issued a press release announcing that the Institutional Review Board at Clinical Pharmacology of Miami has approved the Company&#8217;s Phase 1 Part 3 clinical trial of its lead asset, DA-1726, a novel, dual oxyntomodulin analog agonist targeting both GLP-1 and glucagon receptors. The Phase 1 Part 3 trial will enroll a total of 40 obese, otherwise healthy adult subjects, across two parts, with 20 subjects per part, randomized 4:1 (16 active; 4 placebo). Part 3A is designed to evaluate a one-step titration regimen with 16 mg for 4 weeks followed by 48 mg for 12 weeks, while Part 3B will evaluate a two-step titration regimen with 16 mg for 4 weeks, 32 mg for 4 weeks, and 64 mg for 8 weeks. The study will assess safety, tolerability, pharmacokinetics (&#8220;PK&#8221;), and pharmacodynamics of DA-1726. Primary endpoints include monitoring adverse events (&#8220;AEs&#8221;), serious adverse events, treatment-emergent adverse events, and AEs leading to treatment discontinuation. Secondary and exploratory endpoints include PK profiling and evaluation of metabolic, glycemic, lipid, and body composition measures, including weight, waist circumference, and body mass index, and other cardiometabolic measures. The Company plans to initiate initial dosing in April 2026, with data expected in the fourth quarter of 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 3.8pt 8pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Forward-Looking Statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 3.6pt 0pt 0pt;">This Report, including Exhibit 99.1 attached hereto, contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on current expectations and are not guarantees of future performance. Further the forward-looking statements are subject to the limitations listed in Exhibit 99.1 and in the other reports of the Company filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 3.6pt 0pt 0pt;"><span style="font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p><a id="_bd9bc5dc_1d19_4eec_8003_baf1950bdbe8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(d) Exhibits</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:0.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:89.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style=""><td style="vertical-align:bottom;width:9.51%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit<br/>Number</p></td><td style="vertical-align:bottom;width:0.73%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:89.75%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit Description</p></td></tr><tr style="height:15.75pt;"><td style="vertical-align:top;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:0.73%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:89.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mtva-20260318xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release dated March 18, 2026.</span></a></p></td></tr><tr style="height:15.75pt;"><td style="vertical-align:top;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:0.73%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:89.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (embedded within Inline XBRL document).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;background:#000000;margin:0pt 0pt 8pt 0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 3.6pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_86d7d8b6_f0a0_4d5c_b50c_f36b89c0a653"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Signatures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:45.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#8203;&#160;&#8203;&#160;&#8203;</p></td><td colspan="2" style="vertical-align:bottom;width:49.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">METAVIA INC.</b></p></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:21.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt -14pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:21.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt -14pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:21.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt -14pt;">Date: March 18, 2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:bottom;width:45.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Hyung Heon Kim</p></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Hyung Heon Kim</p></td></tr><tr style=""><td style="vertical-align:bottom;width:48.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">President and Chief Executive Officer</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>mtva-20260318xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.2.0.21--><!--Created on: 3/17/2026 07:11:51 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><div style="height:0pt;position:relative;width:100%;"><div style="height:66pt;left:13.87%;max-width:86.13%;position:absolute;top:-38.5pt;width:342.17pt;z-index:251658240;"><div style="height:65.5pt;left:0pt;padding-bottom:0.5pt;position:relative;width:342.17pt;"><img src="mtva-20260318xex99d1001.jpg" alt="Graphic" style="height:65.5pt;width:342.17pt;"></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;min-height:57.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><b style="color:#201f1e;font-family:'Calibri','Helvetica','sans-serif';font-size:14pt;font-weight:bold;">MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-style:italic;">16-Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Segoe UI';font-size:9pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">CAMBRIDGE, Mass., March 18, 2026 &#8211; MetaVia Inc. </b><font style="font-family:'Calibri','Helvetica','sans-serif';">(Nasdaq: MTVA),</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';">a clinical-stage biotechnology company focused on transforming cardiometabolic diseases</font><font style="font-family:'Calibri','Helvetica','sans-serif';">, today announced that the Institutional Review Board (IRB) at Clinical Pharmacology of Miami has approved the Company&#8217;s Phase 1 Part 3 clinical trial of its lead asset, DA-1726, a novel, dual oxyntomodulin (OXM) analog targeting both GLP-1 (GLP1R) and glucagon (GCGR) receptors. The approval enables initiation of Part 3 of the Phase 1 program, which consists of two 16-week titration cohorts evaluating one-step and two-step dose-escalation strategies intended to safely reach higher target doses and further optimize tolerability.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">The Phase 1 Part 3 trial will enroll a total of 40 obese, otherwise healthy adult subjects, across two parts, with 20 subjects per part, randomized 4:1 (16 active; 4 placebo). Part 3A is designed to evaluate a one-step titration regimen with 16 mg for 4 weeks followed by 48 mg for 12 weeks, while Part 3B will evaluate a two-step titration regimen with 16 mg for 4 weeks, 32 mg for 4 weeks, and 64 mg for 8 weeks. The study will assess safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of DA-1726. Primary endpoints include monitoring adverse events (AEs), serious adverse events (SAEs), treatment-emergent adverse events (TEAEs), and AEs leading to treatment discontinuation. Secondary and exploratory endpoints include PK profiling and evaluation of metabolic, glycemic, lipid, and body composition measures, including weight, waist circumference, and body mass index (BMI), and other cardiometabolic measures.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">&#8220;This IRB approval marks a key milestone in the advancement of DA-1726 and builds on the program&#8217;s increasingly compelling clinical profile across efficacy, safety, and tolerability,&#8221; stated Hyung Heon Kim, President and Chief Executive Officer of MetaVia. &#8220;In earlier cohorts, the 48 mg dose produced approximately 9% weight loss, meaningful reductions in waist circumference, improved blood sugar control, and early signals of direct liver benefit, all with a favorable safety profile. Our upcoming 16-week titration studies to 48 mg and 64 mg doses are designed to build on these results and further highlight DA-1726&#8217;s favorable tolerability and potential advantage relative to currently marketed therapies that require slower, more extended titration before achieving full therapeutic dosing. With initial dosing expected to begin in April and data expected in the fourth quarter of 2026, we believe these results will further de-risk the program and support advancement of DA-1726 into later-stage development, reinforcing its potential as a differentiated, next-generation GLP-1-based therapy that could offer meaningful advantages over existing options.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">About DA-1726</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP1R/GCGR dual agonist for the treatment of obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH) that is to be administered once weekly subcutaneously. DA-1726 acts as a dual agonist of GLP-1 receptors (GLP1R) and glucagon receptors (GCGR), leading to weight loss through reduced appetite and increased energy expenditure. DA-1726 has a well understood mechanism and, in pre-clinical mice models, resulted in improved weight loss compared to semaglutide (Wegovy&#174;), a leading GLP-1 receptor agonist. Additionally, in pre-clinical mouse models, DA-1726 elicited similar weight reduction, while consuming more food, compared to tirzepatide </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">(Zepbound&#174;) and survodutide (a drug with the same MOA), while also preserving lean body mass and demonstrating improved lipid-lowering effects compared to survodutide. In the Phase 1 multiple ascending dose (MAD) trial in obesity, the 32 mg dose of DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist circumference reduction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">About MetaVia</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing vanoglipel (DA-1241) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP-1 receptor agonists such as semaglutide. In a Phase 1 multiple ascending dose (MAD) trial in obesity, DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist reduction. Vanoglipel is a novel G-protein-coupled receptor 119 (GPR119) agonist that promotes the release of key gut peptides GLP-1, GIP, and PYY. In pre-clinical studies, vanoglipel demonstrated a positive effect on liver inflammation, lipid metabolism, weight loss, and glucose metabolism, reducing hepatic steatosis, hepatic inflammation, and liver fibrosis, while also improving glucose control. In a Phase 2a clinical study, vanoglipel demonstrated direct hepatic action in addition to its glucose lowering effects.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">For more information, please visit www.metaviatx.com.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Forward Looking Statements</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">Certain statements in this press release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &quot;believes&quot;, &quot;expects&quot;, &quot;anticipates&quot;, &quot;may&quot;, &quot;will&quot;, &quot;should&quot;, &quot;seeks&quot;, &quot;approximately&quot;, &#8220;potential&#8221;, &quot;intends&quot;, &quot;projects&quot;, &quot;plans&quot;, &quot;estimates&quot; or the negative of these words or other comparable terminology (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including, without limitation, those risks associated with MetaVia&#39;s history of net losses, the sufficiency of its existing cash on hand to fund operations and raising additional capital; adverse global economic conditions; MetaVia&#8217;s ability to execute on its commercial strategy; the ability to obtain regulatory approval through the development steps of MetaVia&#39;s current and future product candidates; the ability to realize the benefits of the license agreement with Dong-A ST Co. Ltd., including the impact on future financial and operating results of MetaVia; the cooperation of MetaVia&#39;s contract manufacturers, clinical study partners and others involved in the development of MetaVia&#39;s current and future product candidates; potential negative interactions between MetaVia&#39;s product candidates and any other products with which they are combined for treatment; MetaVia&#39;s ability to initiate and complete clinical trials on a timely basis; MetaVia&#39;s ability to recruit subjects for its clinical trials; whether MetaVia receives results from MetaVia&#39;s clinical trials that are consistent with the results of pre-clinical and previous clinical trials; impact of costs related to the license agreement, known and unknown, including costs of any litigation or regulatory actions relating to the license agreement; the effects of changes in applicable laws, regulations or Nasdaq listing rules; the effects of changes to MetaVia&#39;s stock price; and other risks and uncertainties described in MetaVia&#39;s filings with the Securities and Exchange Commission, including MetaVia&#39;s most recent Annual Report on Form 10-K. Forward-looking statements speak only as of the date when made. MetaVia does not assume any obligation </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Contacts:</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">MetaVia</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">Marshall H. Woodworth</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">Chief Financial Officer</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">+1-857-299-1033</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;">marshall.woodworth@metaviatx.com</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Rx Communications Group</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">Michael Miller</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">+1-917-633-6086</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">mmiller@rxir.com</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mtva-20260318x8k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mtva-20260318x8k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !3 :X# 2(  A$! Q$!_\0
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MV7RT^Z2/3J***^6/U8^/?BC_ ,G=:1_U^Z?_ "2OL*OCWXH_\G=:1_U^Z?\
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mtva-20260318xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mtva-20260318xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "# JT# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=VU?WA11161UA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ>DZO9:[I\%]IUW#?6<ZAXKBW<.CJ>A!'!%7*\)JVC/O4U)71\Y_MR:BMO\
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M^:\'X#^T<[P]-KW8OF?I'7\79?,^EZ***_(C^Q0HHHH **** "BBB@ HHHH
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M"7VF>7[L40/8NY51_O5_/MXK\3ZCXV\3ZMXAUBX^U:KJMW+>W<V N^61R[G
MX R3P.!04E<_=3X._MB?"OX\^*Y?#G@SQ!+J6KQVKWC02V$\ \I656(:1%!(
M+KQG/7T->U5^(O\ P3=U!K']L;P*@E,4=RE_"X#8#C[%.P4^OS*O'J!7[=4"
M:L%%%% @HHHH **** "BBB@ HHHH ***_._]K7_@HE\0?@+\>_$G@?0M$\/7
MFEZ:MJT4U_#,TS>9;12MN*RJ.KD#CIB@=KGZ(45\*?L/?MV>./VF/B]J'A7Q
M)I&A6%A;Z--J*RZ;#*DAD2:% "7D88Q*W;L*^ZZ!;!1110 4444 %%%% !11
M10 5D>*?%&G^#="N=7U1Y(K"V ,LD<32%02!G"@G&2*UZIZQI5MKNE7FG7D8
MFM+N)H94/\2L,$?D:N'+S+GVZF-95'2DJ+2G9VOM?I?RN>=:3^TM\/M:U2TT
M^UUEVN;J58(@]I*@+L< $E<#DCDUZC7YH>-_"MUX#\8ZGHERS">QG*+)T+KU
M1QZ94J?QK[S^"?CY?B-\.M+U1W#7R+]FO!W$R !C_P "&&^C5])FN5TL)2A7
MP[;A+O\ @?F?"7%6*S?%5\!F,8QJPV236SM):MZIV_I'>4445\P?J04444 %
M%%% %/6-6M=!TJ\U*^E$%E:1-/-*03M11DG Y/ [5YC'^U-\.975$UB=W8@*
MJV,Y)/I]RN-_;%^(/]D^&K/PK;28N=3837.#RL"'@?\  G _!#7C_P"RY\/O
M^$T^)$-[<1;].T8"[DR.&DS^Z7\P6_X :^IP>5T)8*6,Q3:6MK?\-U9^3YSQ
M5CJ>>4LFRN,6W92<DW9O5[-:1CJ_^ ?=2-O16 (!&<$8-97B;Q9I'@W3&U#6
MM0ATZT4[?,F;&X^BCJ3[#FM>OE3]M31=8GO- U%(Y9=%BB>)BF2L4Q;)+>FY
M<8/^R:\? 8:.,Q,:,Y63/M>(<SJY-EM3&T:?/*-M.FKM=VZ+<^@?!OQ1\+?$
M!I5T'6(+^6(9>$920#UV, <<CG&*ZJO@C]F;1M6O_B[HMSI\4H@M&>2ZF .Q
M(MC AC[YP/<U]["NC-<%3P%=4J<KIJ_FCS>$\]Q&?X!XG$4^22DUI>ST3NK^
MMNHM%%%>,?:A1110 4444 %%%% !1110 5X9^UA\"D^,'@5KK3H ?$VDJTUF
MRCYITZO 3[XR/1@.F37N=%;4JLJ,U4ANCDQ>%I8VA+#UE>,E_7W'XNO&T3LC
MJ4=3AE88(/H:;Q7U3^V[\!SX2\0?\)SHMMMT?5)=M_'&.+>Y/._'97Y/LP/]
MX"OE:OT3#UXXFFJD>I_.>88&KEV)EAJNZZ]UT9W?PN^-OB[X0:AY_AW5&CMF
M;=+I]Q^\MICQG<F>#P/F7#<=:^Y?@U^V9X2^))@T_667PQKKX417,@-O,W/W
M)>!GI\K8.3@9K\WZ*YL5@*.*UDK/NOZU/2RS/L9E;4:<N:'\KV^7;Y'V/^W3
M?^?\0] M@VZ.+2A*,'C+RR _^@"OFRL)_%6IW/V<7MW-?I;Q""(7$A<QQ@DA
M%)Z $G Z<UIV>HPW@^1L/W1NM=V$I>PHQI7V/+S/%_7\74Q5K<SV[:%JNE\!
M^/-7\ :I=7>C71LY[RU>RDE4?,L;D$E?0Y48/:N:HKK:C+22NCS%*<-:<G%]
MUNCI'9G8LQ+,QR23DDTVHK67S[='[XP?K4M>TG=71^;3BX2<9;H6OT7^"_A4
M^#/AAX>TMXS'<+;+-.K=1+)\[@_0L1^%?"?PI\+#QI\1= T=T62"XNE,ZL<
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M@^[F/:H]R10.Q].45S_@WX@^&?B)I@U'PQK^G:_8DD>?IURDR9'494GD5T%
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MUTG@CX80Z/Y=[J@2XO>JQ=4B/]3^E=^!BO#Q..O[E+[S[++LEM:KBEZ+_/\
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M_P B/X>_[!UO_P"BEK=K\OJ_Q)>K/ZJPO^[T_P#"OR"BBBLCJ"DI:* /@?\
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M!!)(KED2,@M\I/=L?A7V500]PK\1_P#@I+_R>1XY_P"N>G_^D,%?MQ7XC_\
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MEI]H& OF(RY^K GU)K2\;_\ !4KXR^*;">STTZ/X:24 "XL+4O<)ZX9V*_\
MCM!/*S[L_;H_:[TS]GSX>WNCZ/?1R^/]7@:&PMXF#-9JP*FY<<XV\[0?O,!V
M!Q^*-=-I]CXI^,?CN"UA^W>)O%&L7"QJ9':::>1N!ECS@>IX 'H*M_%_X<7/
MPB^).N>#KRZCO+S1Y5MIYX00C2;%+[<\[=Q(!."0!P.E!25CZZ_X)"_\E[\6
M_P#8LR?^E5O7ZT5^2_\ P2%_Y+WXM_[%F3_TJMZ_6B@A[A1110(0U\)?M/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mtva-20260318.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.2.0.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/17/2026 7:11:56 PM-->
<!--Modified on: 3/17/2026 7:11:56 PM-->
<xsd:schema targetNamespace="http://metaviatx.com/20260318" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mtva="http://metaviatx.com/20260318">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://metaviatx.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mtva-20260318_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mtva-20260318_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>mtva-20260318_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.2.0.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/17/2026 7:11:56 PM-->
<!--Modified on: 3/17/2026 7:11:56 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>mtva-20260318_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.2.0.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/17/2026 7:11:56 PM-->
<!--Modified on: 3/17/2026 7:11:56 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mtva-20260318.xsd#DocumentDocumentAndEntityInformation" roleURI="http://metaviatx.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://metaviatx.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_639093715162570480" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_639093715162570480" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_639093715162570480" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_639093715162570480" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_639093715162570480" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_639093715162570480" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_639093715162570480" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_639093715162570480" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_639093715162570480" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_639093715162570480" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_639093715162570480" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_639093715162570480" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_639093715162570480" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_639093715162570480" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_639093715162570480" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_639093715162570480" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_639093715162570480" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_639093715162570480" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_639093715162570480" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_639093715162570480" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_639093715162570480" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_639093715162570480" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_639093715162570480" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_639093715162570480" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 18, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 18,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">METAVIA INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2389984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">545 Concord Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">702-9600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MTVA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mtva-20260318x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metaviatx.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mtva-20260318.xsd</File>
    <File>mtva-20260318_lab.xml</File>
    <File>mtva-20260318_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mtva-20260318x8k.htm">mtva-20260318x8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mtva-20260318x8k001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mtva-20260318x8k.htm": {
   "nsprefix": "mtva",
   "nsuri": "http://metaviatx.com/20260318",
   "dts": {
    "schema": {
     "local": [
      "mtva-20260318.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mtva-20260318_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mtva-20260318_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mtva-20260318x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://metaviatx.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mtva-20260318x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mtva-20260318x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://metaviatx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-26-029912-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-26-029912-xbrl.zip
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MQ'FXFB*&C^&1B,F:(IR,V1-UV+-+28CX,,A"Y5%O[L]2<?[C3]FKV=8'@,#
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MA/&R*F_7,S<<GI3M]XBR1%0'8?!NV,$.,-T1#/X4]GT8N<T<H+B+8^[5-'V
M(T[8X,%%.@.G"4:S$X!OA*!&'3B.A1_121<#PIG9T.&[* \IH(#[;7Q?YQ5S
MT*"U'"!\)S1\!OTJZ 2',2HA.VLNYLGV[.3A.$( ''06123>0KLU2:FPL6)P
M!*^(MX6<A-4<C7UP$@(G@19@'!C@0+@3^.!!HAA02+A;QR9]]/G@1%*@CH,Z
M7F*S2H  FPSB((P*J 8NXV"R$706/RQ&%<<87%4&#SA\75 >,3+-@L*\0A[X
MJ2=AR')7TXOQ&,MD>U<W>864)*)\0A$&#M_4FAVT#%UT24A@-. <3V[;+CP3
MLS5]$6EA(L#B-IB'XMAFVI"YS8 DRA(:XRZ(3D>XV4-B1>Q K0GL+'*W$*?,
MHQ\P!@C<+=;@#!+RHX>2+8%E@;TMCC;6)M\_'Z6[>Z,$I"+K/MUS32+1_>1;
MUO#,L=:S/=U(?]8.MOG!)PR!C/FF=Z$#1KSQRFBT+:+1-$<;?BE;JF\GL<@,
M6=-#!F8X=\+2C-_B8(L-TTU"$!W.YX#AJ(L]CY/)(L@AI _O4S9VJ4><E(MY
MP&60 $89NJ'W29C$2/$IE/$=L=4MAF3<%U&=S<E7:8?Y+S+IV9H<D3ZD0*8H
ML7Y!ST(D"?(HYE,\%4!QS99"M@6#"M/AT?SH;F-!SMWIMO))XOFUD>4"T?D!
M<5 G]?.#V6)KTJ"%6&4RXHS'MK*3F*$5U!9 $8G+]^Q9<#B["W@*J+5 R0(^
MTG._YUAB(6%A>L9.5A]@2;&8[8 "4XFUPG"09[R07"8T%+OQ65MBCF3G&P0>
M@7&P3?JY7?EI=9;ESX@BL#$SS3ZQ%-UJT"))E0M*.=6"][$C9]*NY?N'"%+#
MTC&4DFP2TBY9"FYK94-I8]>5VR49J[:B.R4'NTLU+!^/D0?;H*(7YK6OF4UJ
M,)LT/2GO+K,0S"V^:-5@M]HNW>R;BX4:CR%0J6#,\.L"\S!G@+U9@#=;@$R%
MSD$E@!E24);$#P/XA4&CQ0) 34:!12*RE9N"N@1[<7<,FC3QXFQ"B@!F.PP
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MQ[2+ER6H@T;)A:O5:."4(U$&H#V'!>&LG5@[_6G=S]Q\E:X*V 9_]72]ES5
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M$28YF2MQ\N9HO;$O$$5#!@N)F--@XT4OAV-J,NBDM<[$F6/$G(GY#4(W <S
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M82TR,#(V,#,Q."YX<V102P$"% ,4    " "I0')<<391JX(%   T/@  %0
M            @ $U P  ;71V82TR,#(V,#,Q.%]L86(N>&UL4$L! A0#%
M  @ J4!R7*_CA)IT!   0R<  !4              ( !Z@@  &UT=F$M,C R
M-C S,3A?<')E+GAM;%!+ 0(4 Q0    ( *E <ESWVN&*WAH  $W&   4
M          "  9$-  !M='9A+3(P,C8P,S$X>#AK+FAT;5!+ 0(4 Q0    (
M *E <ER[61R)P"$  ),C   7              "  :$H  !M='9A+3(P,C8P
M,S$X>#AK,# Q+FIP9U!+ 0(4 Q0    ( *E <EQ6FRNCTQ$  &E$   8
M          "  99*  !M='9A+3(P,C8P,S$X>&5X.3ED,2YH=&U02P4&
/  8 !@"2 0  GUP

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>mtva-20260318x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mtva-20260318.xsd" xlink:type="simple"/>
    <context id="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638287</identifier>
        </entity>
        <period>
            <startDate>2026-03-18</startDate>
            <endDate>2026-03-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_URXl72dnfkWR-I_AemKwCA_1_1">0001638287</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_uOaa9lgrOkSeFNrK6tDWhQ_2_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_7hDbU-YJI0ezpq8jnyPwNQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_4lQoiCeT-U60TfTPnlFUmw">2026-03-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_XktjUJNBsUimWCLW5IRopg">METAVIA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_M3qaim0Qv0Sg1qZkC7p9Lw_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_xz2eznqK_0uSO0GwGp43QA_1_2">001-37809</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_w8q37vOyWEqUQm5AsInH1g_1_4">47-2389984</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_EaNrAZHOh0OMhh9XN016Cg">545 Concord Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_i2ozApFXb0eomZ_YyPPKLQ">Suite 210</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_XFalxxEX60-f4IofNfLOxw">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_TAoDygC1pEqd6zsD864Dyg">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_FCA4F41oPEa6veF6N967iA_1_2">02138</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_P6e_vh-rkEukpienKzgaLQ">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_h6p6l6nvokyF2OkuDUVMLQ">702-9600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_EA6AWe_gB0Cd4VIt-7RBKQ_1_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_G5ZH-Gs2BkiA1FafYlElgA_2_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_WiRExuoP806a_ij_tQeRtw_3_0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_2n2ekDY9L0yyih0yUBLeTw_4_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_zumNpxG6mEi4rhugSZ-rUw_2_0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_aWQu5QanLEigH6bUjLMBrQ_2_2">MTVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Tc_H5oSULDcT0OdwMSPv8ikHg_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_3_18_2026_To_3_18_2026_StaHu-HiqUyFa5-3KYufFw"
      id="Narr_PlZ8jYcOwkmwA35Y42O0OQ">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
